Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.7456
-0.0368-4.70%
Post-market: 0.74560.00000.00%19:53 EDT
Volume:424.14K
Turnover:321.06K
Market Cap:34.85M
PE:-0.83
High:0.8000
Open:0.7900
Low:0.7207
Close:0.7824
Loading ...
Aug 07, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Nov 30, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]